Bajaj Healthcare launches Covid drug 2-DG under DGJAJ brand
Bajaj Healthcare Limited (BHL) said that it has launched API and formulation of 2-Deoxy-D-Glucose (2-DG), an antiviral drug used for the treatment of moderate to ... Read More
Bajaj Healthcare Limited (BHL) said that it has launched API and formulation of 2-Deoxy-D-Glucose (2-DG), an antiviral drug used for the treatment of moderate to ... Read More